USER MANUAL (Instruction for Use) SW 6.1
Introduction
Version 6.1.6 dated 2020-01-31 EN Page 46 of 201
Penning of the patient, contusion, harm of the patient, user or third parties
Electric shock
The residual risks associated with SCHWIND AMARIS Application Software are as follows:
Temporarily reduced vision quality
Surgeon may be confused while treatment is considered as wrong
Poor visual outcome like under- or overcorrection, irregular correction
Incorrect therapy
Bodily harm of patient or surgery personel
3.3.6 Biocompatibility of Touchable Parts
All touchable materials of the SCHWIND AMARIS are rated as biocompatible. There are no known
problems, such as allergic reactions, which might occur by using the product.
If you recognize any effects, please contact the SCHWIND eye-tech-solutions service department
or customer support.